摘要
目的观察联合应用依达拉奉和纳洛酮治疗急性脑出血的临床疗效。方法选取192例急性脑出血患者,随机选择95例为对照组,给予常规治疗加依达拉奉(国药集团国瑞药业有限公司,国药准字H20080056)30 mg,ivgtt,2次/d,疗程14 d。余97例为观察组,给予常规治疗加依达拉奉联合纳洛酮(海南灵康制药有限公司,国药准字H20070291)治疗,30 d后评定疗效。结果观察组和对照组的有效率分别是91.75%和75.79%,对照组与观察组比较,差异有统计学意义(P﹤0.05)。结论依达拉奉联合纳洛酮治疗急性脑出血较单独使用依达拉奉临床疗效更好,值得推广应用。
Objective To observe the curative effect of edaravone and naloxione in the treatment of acute intraeerebral hemorrhage. Methods A total of 192 patients with acute intracerebral hemorrhage were randomly divided into two groups , the control group （n = 95） receiveds routine treatment and edaravone 30 rag, ivgtt, bid for 14 days therapy,while, the study group （n = 97） receiveds routine treatment and edaravone and naloxione, evaluating the curative effect after treating for 30 days. Results Effective rates in the study and control groups were 91.75% and 75.79% respectively （P〈 0.05）, There were signifieantly diffence between the two groups. Conclusion Using edaravone and naloxione for treating acute intracerebral hemorrhage is more effective as compared with usin~ edaravone and worth heln~ ~nreacl,~d
出处
《中国现代医生》
2012年第18期67-68,共2页
China Modern Doctor
关键词
依达拉奉
纳洛酮
自由基清除剂
急性脑出血
Edaravone
Naloxione
Free radical scavenger
Acute intracerebral hemorrhage
